CompletedNot Applicable

Reduce Emotional Symptoms of Insomnia With SleepTreatment

United States21 participantsStarted 2020-09-01

Plain-language summary

The purpose of this research is to test whether Mindfulness-Based Therapy for Insomnia (MBTI) significantly reduces symptoms of insomnia and cognitive arousal in patients with treatment-resistant insomnia.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Determination of insomnia (ISI\>10) * Inadequate response to prior insomnia psychotherapy (e.g., CBTI) and/or pharmacotherapy per patient report. Exclusion Criteria: * Age \< 18 * Current use of antidepressants for depression * Bipolar or Seizure disorders * Known sleep disorders other than insomnia (e.g. obstructive sleep apnea, narcolepsy, restless leg syndrome).

What they're measuring

Insomnia Severity Index

Timeframe: Pre-treatment, post-treatment (7 weeks following initiation of treatment), and 6 months follow-up (6 months following conclusion of treatment)

Five Facet Mindfulness Questionnaire-15 (FFMQ-15)

Timeframe: Pre-treatment, post-treatment (7 weeks after initiation of treatment), and 6 months follow-up (6 months following treatment conclusion)

Trial details

NCT IDNCT03724305

SponsorHenry Ford Health System

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-04-10

Results submitted2023-07-19

View on ClinicalTrials.gov More Insomnia trials